PULSE BIOSCIENCES, INC. — Director's Dealing 2021

Aug 20, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2021-08-19

Reporting Person: Levinson Mitchell E. (Director, Chief Strategy Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-19	Stock Option (right to buy)	$21.12	A	65510	Acquired	2031-08-19	Common Stock (65510)	Direct

Footnotes

F1: 50% of the shares subject to the option will vest in equal annual installments on the second, third and fourth anniversary of the grant date, and the other 50% of the shares subject to the option will vest upon the achievement of performance objectives established by the Compensation Committee of the Issuer, with vesting targets set at 25% (8,188 option shares) over the following four years on the anniversary of the grant date. All vesting is subject to the Reporting Person's continued service through each vesting date.